Health Care: Drugs

Cyclacel Pharmaceuticals Inc (CYCC: NASDAQ)

$1.91 0.2 | 11.7%
07/21/17 - 03:59 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 843.00K 1.94M 1.73M 1.08M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 843.00K 1.94M 1.73M 1.08M
Selling, General, and Administrative Expenses 5.52M 5.73M 5.89M 7.78M
Research & Development 9.48M 12.38M 18.28M 11.28M
Operating Income before D & A (EBITDA) -14.15M -16.17M -22.44M -17.97M
Depreciation & Amortization 133.00K 210.00K 174.00K 70.00K
Interest Income 37.00K 9.00K 6.00K 13.00K
Other Income - Net 339.00K -325.00K -218.00K 6.08M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -13.91M -16.70M -22.82M -11.95M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -13.91M -16.70M -22.82M -11.95M
Income Taxes -1.98M -2.14M -3.24M -1.67M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -11.79M -14.34M -19.41M -10.21M
Net Income From Discontinued Operations 0.00 0.00 19.00K 57.00K
Net Income From Total Operations -11.79M -14.34M -19.39M -10.15M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -11.79M -14.34M -19.39M -10.15M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-11.79M -14.34M -19.41M -10.21M
Preferred Dividends
Net Income Available To Common -11.99M -14.54M -19.61M -19.54M
Basic EPS from Continuing Ops. -3.50 -5.36 -10.68 -15.48
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -3.50 -5.36 -10.68 -15.48
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.12
Basic EPS, Total -3.50 -5.36 -10.68 -15.36
Basic Normalized Net Income/Share -3.50 -5.36 -10.68 -15.48
EPS fr Continuing Ops. -3.50 -5.36 -10.68 -15.48
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -3.50 -5.36 -10.68 -15.48
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.12
EPS, Total -3.50 -5.36 -10.68 -15.36
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-3.50 -5.36 -10.68 -15.48
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CYCC

Latest CYCC Headlines from TheStreet

More Financial News for CYCC

Press Releases for CYCC

See All Press Releases

Partner Headlines for CYCC

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter